NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹50 Cr | ₹46 Cr | ₹26 Cr | ₹6.43 Cr | ₹12 Cr |
What is the latest Capital Work in Progress ratio of NGL FINECHEM ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹50 Cr |
| Mar2024 | ₹46 Cr |
| Mar2023 | ₹26 Cr |
| Mar2022 | ₹6.43 Cr |
| Mar2021 | ₹12 Cr |
How is Capital Work in Progress of NGL FINECHEM Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹50 Cr | 9.24 | |
| Mar2024 | ₹46 Cr | 73.00 | |
| Mar2023 | ₹26 Cr | 309.08 | |
| Mar2022 | ₹6.43 Cr | -47.93 | |
| Mar2021 | ₹12 Cr | - | |
Compare Capital Work in Progress of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,334.2 Cr | -2.7% | 4.9% | 122.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,000.0 Cr | 1.5% | 6.9% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,076.0 Cr | -0.8% | 1.7% | 14% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,510.0 Cr | 3.2% | 9% | 44.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,921.0 Cr | 1.1% | 5% | 16.4% | Stock Analytics | |
| CIPLA | ₹106,150.0 Cr | 0.3% | -1.3% | -9% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -2.7% |
4.9% |
122.1% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses